Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.
暂无分享,去创建一个
G. Veres | M. Papp | P. Lakatos | A. Arató | G. Kökönyei | A. Dezsőfi | Á. Cseh | K. Müller | Kriszta Molnár | P. Golovics | B. Lovász | D. Szabó